This could be attributed to the AR-mediated upregulation of glucose transporters (GLUTs) in prostate cancer cells, as demonstrated in several studies, including GLUT1 [9,32], GLUT3 [33] and GLUT12 [34]. Here, AR is linked to prostate cancer.